Cellular senescence is considered a key biological program that can exert both protective and potentially pathogenic effects in tissues across the lifespan. If senescent cells persist, they are associated with chronic inflammation, disturbed tissue homeostasis and diverse disease phenotypes. In recent years, a clinically highly relevant field of research has emerged from this: Senotherapies – in particular senolytics (selective elimination of senescent cells) and senomorphics (modulation of senescence-associated signaling and secretion patterns) – are widely studied in preclinical models, while human evidence to date comes mainly from early, small studies or from indirect clinical data sets.
You May Also Like
- Viloxazine for ADHD
A non-stimulating option—but with limited evidence
- Preclinical study on phytotherapeutic agent
Active ingredient combination of peppermint and caraway oil modified fecal microbiota
- Casuistry
Rituximab used effectively against IgG4-RD colitis
- Sarcoidosis
New options from JAKi to mTOR
- Head and neck squamous cell carcinoma
Precision immunotherapy and local treatment
- From symptom to diagnosis
Abdominal pain – Prostate cysts
- Multimodal Parkinson's Treatment
Positive Effects of a Music-Based Intervention
- Psychooncology